Literature DB >> 8884618

Method for single-trial readiness potential identification, based on singular spectrum analysis.

A Mineva1, D Popivanov.   

Abstract

This paper presents a brief description and the advantages of the singular spectrum analysis (SSA). SSA has recently been recommended for analysis of short, noisy time series. The method was applied to single trials of EEG activity at Cz, Fz, C4, Pz and C3, recorded 3.6 s prior to and 1.2 s after the onset of a voluntary motor act. This specific activity is known in its averaged form as readiness potential (RP) and is considered to reflect the preparation of the voluntary movement. However, some physiological investigations require identification of the parameters of single-trial RPs-their onset and successive phases. SSA is based on analysis of the principal components in vector space of delay coordinates of time series. As a result, SSA algorithm decomposes real data records to components reflecting the trend, alpha and beta frequency bands, respectively, whose oscillations appear or disappear in different time instants. The latter were interpreted to distinguish different dynamical stages of the movement preparatory process.

Entities:  

Mesh:

Year:  1996        PMID: 8884618     DOI: 10.1016/0165-0270(96)00012-x

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  3 in total

1.  Event-Related Oscillations in Alcoholism Research: A Review.

Authors:  Ashwini K Pandey; Chella Kamarajan; Madhavi Rangaswamy; Bernice Porjesz
Journal:  J Addict Res Ther       Date:  2012-01-12

2.  Breathing is coupled with voluntary action and the cortical readiness potential.

Authors:  Hyeong-Dong Park; Coline Barnoud; Henri Trang; Oliver A Kannape; Karl Schaller; Olaf Blanke
Journal:  Nat Commun       Date:  2020-02-06       Impact factor: 14.919

3.  Intrinsic and climatic factors in North-American animal population dynamics.

Authors:  Nicolas Loeuille; Michael Ghil
Journal:  BMC Ecol       Date:  2004-05-07       Impact factor: 2.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.